After Zepbound-maker Eli Lilly reduced the price of the weight-loss drug, competitor Novo Nordisk has cut the price of weight ...

Wegovy is FDA approved for weight management in certain children ages 12 years and older. The recommended dosage is the same as for adults. This is described in the table. Wegovy and Mounjaro can ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Copyright 2025 The Associated Press. All Rights Reserved. Donna Cooper holds up a dosage of Wegovy, a drug used for weight ...

Novo Nordisk is taking a page out of Eli Lilly’s playbook as the two GLP-1 drugmakers work to fend off compounding pharmacies ...

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

Viking Therapeutics' plans to launch VK2735 with an auto-injector could delay regulatory approval. Click here to read why ...

Novo said its discounted Wegovy would be available in pens of all dosage strengths to uninsured patients or eligible patients with commercial insurance who do not have coverage for obesity ...

The increasing popularity of weight loss drugs like Wegovy, Ozempic, Mounjaro and metformin may have you wondering how all ...

Both Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy cost over $1,300 per month ... In response, Eli Lilly reduced the monthly price of lower-dosage vials of Zepbound by $50 for cash-paying ...